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Abstract
Objective: To evaluate the effectiveness and drawbacks of diversified procedures of limb salvage surgery (LSS), providing a
reference of rational surgical criterion of LSS.
Methods: Fifty eight patients with stage IIB extremity osteosarcoma around knee joint area between 1992 and 2002 were
studied retrospectively. Among them, 43 patients were treated by LSS followed by reconstruction. Reconstruction
approaches included re-implantation of irradiation-devitalized tumor bone (n=12), autoclaving-devitalized tumor bone
(n=8), prosthetic replacement (n=11), allograft transplantation (n=8) and vascularized fibula autograft implantation
(n=4). Amputations were performed in 15 patients. Patients were followed up for 6–16 years.
Results: There were no significant difference between LSS and amputation groups regarding disease free survival and local
recurrence rates. The actuarial 5-year continuous disease free survival and local recurrence rate were 30.0% and 25.0% in
patients of devitalized LSS group, whereas those were 56.5% and 8.7% in patients of non-devitalized reconstruction group.
The complication rate was significantly higher in LSS group compared to amputation group (P=0.003).
Conclusion: LSS with non-devitalized procedures is the optimal treatment for osteosarcoma around knee joint area.
Prosthesis implantation is the preferred option for bone reconstruction following LSS. Prevention and treatment of post-
operative complications should be paid more attention to get good long-term outcomes of surgery.
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Introduction
The survival rate of osteosarcoma has been significantly
improved with the advent of many effective chemotherapeutic
drugs since the late 1970s [1,2]; meanwhile, limb salvage surgery
(LSS) has gradually become the mainstay treatment for osteosar-
coma [3,4] because of its functional and physiological benefits over
traditional amputative procedures. Besides, LSS has also greatly
improved the life quality and enhanced the courage of patients.
However, the question of ‘what modus of LSS is optimal for
patient in terms of effectiveness and economy?’ still remains
perplexing for most of surgeons as miscellaneous procedures of
LSS for osteosarcoma have been widely applied and reported all
over the world in recent years. Few studies have been conducted so
far to explore and evaluate the criteria for the options of
performing limb salvage based on the long-term outcomes after
surgery. These outcomes include but not limited to the disease-free
survival(DFS), local recurrence rates, and postoperative compli-
cations of patients.
In this study, we retrospectively analyzed the surgical outcomes
of 58 patients with osteosarcoma around knee joint who were
treated in our hospital from February 1992 to December 2002,
and attempted to evaluate and compare the effectiveness and
drawbacks of the diversified procedures of LSS in terms of DFS,
local recurrence rate and postoperative complications of patients
with the aim to provide a reference of rational surgical criterion of
LSS for patients.
Materials and Methods
Clinical characteristic
In total, 58 patients (30 males, 28 females) aged 12–55 years
(median age 20.26 years) with pre-operatively or pathologically
confirmed malignant primary osteosarcoma at the particular knee
joint area were enrolled in this study. The sites of osteosarcoma
included the distal femur (n=30), proximal tibia (n=24), and
proximal fibula (n=4).
The histological subtypes of the cases in our study were
classified as osteoblastic type (n=42), fibroblastic type (n=10),
chondroblastic type (n=4) and other type (n=2). All 58 patients
were diagnosed as Enneking stage IIB disease and without local
and distal metastasis at admission.
Treatment
Surgical procedures: All 58 patients underwent surgical
operations, and of the 43 patients who received LSS, wide
resection of tumors was performed based on the Enneking staging
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surrounding cuff (3–5 cm circumference of tumor-free resection
margins) of normal tissue (which was verified by pathological
section) [5]. Two major methods were used for reconstruction:
devitalized approach including re-implantation of irradiation-
devitalized tumor bone (extracorporeally irradiated for 30 min
using 30–50 Gy high-energy x-ray produced by a linear
accelerator; irradiation subgroup, n=12) and re-implantation of
autoclaved-devitalized tumor bone (extracorporeally boiled for
30 min; autoclaving subgroup, n=8), and non-devitalized ap-
proach including prosthetic replacement (hinged knee prosthesis;
prosthetic subgroup, n=11), allograft transplantation (allograft
subgroup, n=8), and vascularized fibula autograft implantation
(autograft subgroup, n=4). Besides, amputation were operated in
another 15 patients (amputation group, n=15).
Chemotherapy: Patients in both LSS and amputation group
received the same protocol of neoadjuvant chemotherapy, which
referred to the Bacci (IOS/OS4) regimen [6], along with the
surgery. The main drugs used included adriamycin, cisplatin, high
dose methotrexate, and cyclophosphamide. Four cycles of
protocols of adjuvant chemotherapy were administered preoper-
atively and two weeks after operation.
Postoperative outcome evaluation and statistical analysis
All 58 patients were divided into 3 groups based on the
treatment they received: G1 (Group 1), amputation group; G2
(Group 2), devitalized LSS group: LSS with reconstruction
approaches including re-implantation of irradiation-devitalized
tumor bone and autoclaving-devitalized tumor bone; G3 (Group
3), non-devitalized LSS group: LSS with reconstruction approach-
es including prosthetic replacement, allograft transplantation, and
vascularized fibula autograft implantation. For each group, the
average duration of DFS, the percentage of actuarial 5-year
continuous disease free survival (CDFS), local recurrence, and the
post-operative complications were calculated and analyzed.
Statistical comparison was made with a-priori contrasts as follows
(G1–G2), (G1–G3), (G2–G3) and (G1–G2 and G3 combined:
Amputation vs. LSS).
Statistical analysis was performed using SPSS 10.0 software.
The likelihood ratio chi-square test was used for significance
testing. Survival rate was analyzed using the Kaplan-Meier
method, and the differences in survival rates were compared
using the log-rank test. The level of significance was set at P,0.05.
Our studies were approved by the ethics committee of Shanghai
Tenth People’s Hospital and the School of Medicine at Tongji
University (Shanghai, China). Informed consent was not needed
since the data were analyzed anonymously. The ethics committee
specifically waived the need for consent.
Results
Until December 2008, all 58 patients were followed up for
ranging from 6 to 16 years (median 10.8 years). During the follow-
up, the clinical information regarding the DSF, local recurrence,
and the post-operative complication including infection, fracture,
and non-union were recorded and used for analysis throughout
this study.
The average duration of DFS was 53.3617.8 months and the
actuarial 5-year continuous disease free survival (5-year CDFS)
was 46.5%. The survival curve monitored for up to 92 months
following the surgery is shown in Figure 1. The overall percentage
of local recurrence and post-operative complications including
infection, fracture, and nonunion were 13.8% (8/58) and 32.8%
(19/58), respectively.
The total 58 patients has been divided into three different
groups (G1 to G3) based on the treatment protocol they received
Figure 1. Kaplan-Meier survival curve of 58 patients with osteosarcoma.
doi:10.1371/journal.pone.0033492.g001
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and G3) were generated individually and shown in Figure 2. The
statistical analysis (log-rank test) was conducted thereafter and
found that there was no pronounced difference between G1 and
G3 (P=0.946), and these two groups had significantly higher DFS
than G2 (P=0.049 between G1 and G2, and P=0.005 between
G2 and G3). For all 3 groups (G1, G2, and G3), the percentages of
5-year CDFS, local recurrence, and post-operative complications
were calculated and compared statistically between different
groups (Table 1). The three parameters for G1, G2, and G3 are
respectively: the percentages of 5-year CDFS 53.3%, 30.0%, and
56.5%; the percentage of local recurrence 6.7%, 25.0%, and
8.7%; the percentage of complication 6.7%, 55%, and 30.4%. The
comparison and statistical analysis showed that the difference in
the percentage of complication after surgery was found between
G1 and G2 (P=0.003), G2 and G3 (P=0.079), and G1 and G3
(P=0.103), but only significant for G1 and G2 (P,0.05). The
percentages of 5-year CDFS and local recurrence were also more
or less different between the three groups, but not statistically
significantly with P.0.05 (shown in Table 1).
When G2 and G3 were combined as one group, the treatment
outcomes in terms of the percentages of 5-year CDFS, local
recurrence, and post-operative complications were derived and
compared to G1 (Table 2), which represents the comparison
between two major surgery protocols: amputation (G1) and LSS
(G2 and G3 combined). Log-rank tests showed no significant
difference in DFS was observed from the survival curves (Figure 3,
P=0.313). The percentages of CDFS, local recurrence, and post-
operative complications for G2 and G3 combined were 44.2%,
16.3%, and 41.8%, respectively, which were different from the
values for G1, but only significantly in terms of post-operative
complication (P=0.012).
When the LSS group (G2 and G3) were divided further into the
5 subgroups, irradiation LSS, autoclaving LSS, prosthetic LSS,
allograft LSS, and autograft LSS, based on the reconstruction
procedure following LSS, the percentages of 5-year CDFS, local
recurrence, and post-operative complication were remarkably
different. The percentages of 5-year CDFS were 25.0%, 37.5%,
54.5%, 62.5% and 50% in the irradiation, autoclaving, prosthetic,
allograft, and autograft subgroup, respectively. The percentages
were 33.3%, 12.5%, 9.0%, 12.5% and 0% for local recurrence,
and 41.7%, 75.0%, 18.1%, 62.5% and 0% for post-operative
complication. No statistical analysis was made due to the
insufficient sample size in some subgroups.
As noted above, the percentage of post-operative complication
was significantly higher in the LSS group (41.8%) compared to the
amputation group (6.7%, P=0.012). The main complication after
LSS was infection, fracture (featuring seroma/serous leak), and
non-union of bone. The overview of the complication occurred
after surgery was summarized here: Eight patients (two in each of
Figure 2. Comparison of Kaplan-Meier survival curves between amputation (G1), devitalized LSS (G2), and non-devitalized (G3)
groups. Log-rank tests showed that disease-free survival was significantly different between G1 and G2 (P=0.049) and G2 and G3 (P=0.005) and no
difference in G1 and G3 was found (P=0.946).
doi:10.1371/journal.pone.0033492.g002
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subgroup, one in allograft subgroup) experienced infections post-
operatively, which occurred in the proximal tibia (n=5) or the
distal femur (n=3) 7–60 days post-surgery; Fractures of grafted
bones occurred in the distal femur and the proximal tibia of six
patients within the irradiated and autoclaved subgroups (n=4)
and the allograft subgroup (n=2), 1–3 years after surgery; Non-
union of bone occurred in the proximal tibia of 4 patients, among
whom two were in the irradiated and autoclaved subgroups and
two were in the allograft subgroup.
Discussion
The treatment of osteosarcoma has been advanced dramatically
over the last two decades by applying LSS combined with
adjuvant chemotherapy.Various surgeries applied along with the
chemotherapeutic drugs including methotrexate, adriamycin, and
cisplatin has greatly increased the survival rates of patients and the
life quality of patients has also been further improved by the
replacement of amputation with LSS [7]. Radical resection, or at
least wide resection, is recommended for stage II osteosarcoma [8–
10]. In our practice, wide resection plus reconstruction along with
chemotherapy was routinely performed for the treatment of
osteosarcoma. Amputation is only considered in patients whose
vessels and nerves have been widely affected by the tumor(s) [11].
Given the differences in prevalence, recurrence rates and post-
operative complications at different sites, our study only included
the cases with tumor at the particular knee joint area. A period of
five or more years of disease-free survival is defined as ‘‘cured’’
with respect to osteosarcoma [12,13]. In our study, Kaplan-Meier
analysis demonstrated that the overall survival curve among all 58
patients reached about 50% after three to five years postopera-
tively. Amputation and LSS surgery could result in the similar
disease-free survival rate. However, when compared the disease-
free survival rate of the patients treated with amputation surgery to
the LSS treatments plus different reconstruction procedures
(devitalized: irradiation and autoclaving, and non-devitalized:
prosthetic, allograft, and autograft), both of amputation and non-
devitalized LSS group had similar survival rates, both of which
were better than non-devitalized LSS group. These data suggest
that the procedure for reconstruction following LSS surgery is
critical for the outcome of the treatment applied for osteosarcoma.
The previous report shows that the relapse and metastasis of
osteosarcoma occurs typically 1–2 years following surgery [14].
The recurrence rate after LSS for osteosarcoma is usually 10–20%
[15,16]. As expected, the recurrence rate in all LSS treated
patients was 16.3% in this study, which is higher than that in
amputation treated group (G1, 6.7%). When looking into the
result further, the reconstruction procedure was found to affect the
local recurrence substantially following LSS surgery: in G2
(devitalized LSS group), the recurrence was 25% and 8.7% for
G3 (non-devitalized LSS group). More specifically, the percentage
of local recurrence after surgery varied much by the different
reconstruction procedure ranging from 33.3% for irradiation to as
low as 0% in autograft subgroup (the case number is only 4). The
percentage of 5-year CDFS was also lower in the irradiated and
autoclaved subgroups (,50%) and relatively high in the prosthetic
(54.5%) and allograft (62.5%) subgroups, which leads to the lower
percentage of 5-year CDFS in devitalized LSS group (30.0%) in
relative to non-devitalized LSS group (56.5%) and amputation
group (53.3%), even not significantly. Once again, the reconstruc-
tion approach was approved to be essential for the long-term
outcome including both 5-year CDFS and local recurrence of the
LSS for the treatment of osteosarcoma. The underlined reason for
lower 5-year CDFS rate and higher recurrence rate in irradiation
LSS subgroup could be explained by the previous research work:
osteosarcomas was reported not sensitive to radiotherapy and the
previous research [17,18] has shown that in vitro osteosarcoma cells
could only be devitalized by a radiation dose of 60,000–
100,000 Gy. The medical equipment available at present
(radiation dose: 30–50 Gy) is not able to produce such high doses
of rediation. Therefore, irradiation is not recommended for
devitalization. Instead, boiling for 30 min or soaking in 95% (v/v)
ethanol for 30 min is preferred. Other in situ devitalization of
tumor-containing bones using microwave heliotherapy [19] or
high intensity focused ultrasound [20] has also been well
developed and reported.
Although LSS has become one major option for the treatment
of osteosarcoma, post-operative complications including infections,
fractures, non-union of bones, and loosening of prostheses are still
of intensive concern. The incidence of LSS-related complications
Table 2. The outcome analysis of LSS treated group (G2 and
G3 combined, n=43).
5-year CDFS Local Recurrence
Post-operative
Complication
Percentage
(%) P value*
Percentage
(%) P value
Percentage
(%) P value
44.2 (9) 0.541 16.3 (7) 0.353 41.8 (18) 0.012
Note: P value was analyzed by comparison to G1.
doi:10.1371/journal.pone.0033492.t002
Table 1. Comparison of outcomes among amputation (G1), devitalized LSS (G2), and non-devitalized LSS groups (G3).
Percentage
(%) 5-year CDFS Local Recurrance Post-operative Complication
G1 (n=15) G2 (n=20) G3 (n=23) G1 (n=15) G2 (n=20) G3 (n=23) G1 (n=15) G2 (n=20) G3 (n=23)
53.3 (8) 30 (6) 56.5 (13) 6.7 (1) 25 (5) 8.7 (2) 6.7 (1) 55 (11) 30.4 (7)
Chi-square
test P value
G1 NA 0.163 0.847 NA 0.154 0.073 NA 0.003 0.079
G2 0.163 NA 0.081 0.154 NA 0.821 0.003 NA 0.103
G3 0.847 0.081 NA 0.073 0.821 NA 0.079 0.103 NA
doi:10.1371/journal.pone.0033492.t001
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operative complications was 41.8% in the LSS group, which was
much higher than that in the amputation group (6.7%), and
devitalized reconstruction procedure (55.0%) had more chance of
post-operatively complication than non-devitalized procedure
(30.4%). Among post-operative complications, infection was the
most common complication, accounting for 61.5% of the cases
with complication. Post-operative infections are usually quite
difficult to treat and amputation is often required eventually. In
our study, infections were more common in the irradiated,
autoclaved and allograft subgroups.This suggests that the
problems including graft rejection, virus infection, and donor-
recipient mismatch need to be better addressed and the prevention
and treatment of post-LSS infections remains a challenge. To
more effectively prevent infections, chemotherapy and radiother-
apy are usually performed two weeks before surgery, followed by
routine administration of prophylactic antibiotics one day before
and during surgery (Note that the patients included in this study
were not treated by radiotherapy). Post-operative fracture, usually
occurred 1–2 years after surgery, ranked second among the
complications in our series, especially in the devitalized LSS
group(20% of incidence). The incidence of fracture was especially
high in the proximal tibia due to the severe impairment of bone
substances after devitalization, poor blood supply in the proximal
tibia, and heavy load on the implants [24]. Bone cement filling and
fixation with interlocking intramedullary nails during the re-
implantation of devitalized bones may achieve lesser stress-
shielding effects and lower post-operative fracture rates. Non-
union of bones is often seen in the proximal tibia, especially in
patients who have undergone implantation of allografts or
autogenous bone grafts, and may also be relevant when poor
blood supply is occurring. Similarly, once a non-union occurs,
prosthesis replacement is usually required. Different techniques
have been proposed to reduce complications and improve
functions of the affected extremities [25–27].
Collectively, LSS combined with adjuvant chemotherapy has
the comparable survival rates of patients with osteosarcoma at
knee joint area, especially by LSS with non-devitalized recon-
struction procedure to those of amputation. Even the incidence of
the post-operative complication is higher, this treatment protocol
can provide the advantage for improving the life quality of patients
over amputation protocol and the complications can be minimized
by using chemotherapy with antibiotics before and after surgery,
choosing the most appropriate reconstruction procedure following
LSS (recommend prosthetic for proximal tibia), and better
prevention and post-operative care to the patients. Our study
shows that the procedure for reconstruction following LSS surgery
is critical for the outcome of the treatment applied for
osteosarcoma. At the current stage, the non-devitalized procedure
including irradiation is not recommended for bone reconstruction
in LSS considering the lower percentage of 5-year CDFS and
higher incidence of local recurrence and post-operative complica-
Figure 3. Comparison of Kaplan-Meier survival curves between amputation group and LSS treated groups (G2 and G3 combined).
The log-rank test suggested that DFS was not significantly different between these two groups (P=0.313).
doi:10.1371/journal.pone.0033492.g003
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if the devitalized procedure has to be considered. Even amputation
has good DFS, lower local recurrence and post-operative
complication, it will be only chosen in patients whose vessels and
nerves have been widely affected by the tumor considering the
long-term life quality of patient.
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